Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Positron Emission Tomography (PET) Imaging of Thrombosis

for
Atrial Fibrillation, COVID-19, Cancer, Thrombosis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT03830320

Phase 1, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

for
Solid Tumor
Location: Orange CA, Long Beach CA
Sponsor: Miller Children's & Women's Hospital Long Beach

Sex: All

Age: 1 - 31

Code: NCT02446431

Early Phase 1, Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

for
Metastatic Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010031

Phase 2, Recruiting

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

for
Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05390827

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

for
Pediatric Cancer, Oncology, Disruptive Behavior
Location: St. Petersburg FL
Sponsor: Johns Hopkins All Children's Hospital

Sex: All

Age: 0+

Code: NCT06346782

Recruiting

Pelvic Health Rehabilitation After Breast and Gynecologic Cancer

for
Gynecologic Cancers, Breast Cancer Female, Incontinence,
Location: Quebec, Edmonton
Sponsor: Laval University

Sex: Female

Age: 18+

Code: NCT06822582

Recruiting

Study of Personalized Cancer Therapy to Determine Response and Toxicity

for
Cancer
Location: Rancho Mirage CA, San Diego CA, La Jolla CA
Sponsor: Shu Mei Kato

Sex: All

Age: 7+

Code: NCT02478931

Recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

for
Advanced Solid Tumors
Location: Cincinnati OH, Houston TX, Salt Lake City UT
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT06096974

Phase 1, Recruiting

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

for
Pancreas Cancer, Locally Advanced,
Location: Miami FL
Sponsor: Baptist Health South Florida

Sex: All

Age: 18+

Code: NCT05679674

Recruiting

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

for
Childhood Malignant Solid Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 0 - 17

Code: NCT06915727

Phase 3, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Orlando FL, Birmingham AL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase 1, Phase 2, Recruiting

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

for
Cancer, Advanced Cancer, Advanced Solid Tumor,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05166694

Recruiting

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

for
Mesothelioma, Epithelioid Hemangioendothelioma(EHE),
Location: Houston TX
Sponsor: BridGene Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06452160

Phase 1, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Pittsburgh PA, Nashville TN, Fort Worth TX,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

Psychophysical Studies of Cancer Therapy Pain

for
Advanced Cancer, Pain
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00515060

Recruiting

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06565260

Recruiting

Phase I Human Analytics (HALO) Study

for
Cardiovascular Diseases, Cancer, Dementia,
Location: Indian Wells CA
Sponsor: HALO Diagnostics

Sex: Male

Age: 45 - 70+

Code: NCT05423860

Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

for
Breast Carcinoma, Esophageal Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00991094

Recruiting

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

for
Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05733091

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial